Live Breaking News & Updates on Unmet Social Needs

Stay updated with breaking news from Unmet social needs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cyprus has among the lowest rates of children with...

Cyprus is among the countries with the lowest rates of children with unmet medical needs in the EU according to data released by Eurostat.
But. ....

UnMet Gala raised $1.5-million for Toronto's affordable housing, vulnerable seniors, at-risk youth, and more

The cultural/visual mash-up was the brainchild of Krystal Koo Cooper and Fernanda Dovigi, co-chairs of the inaugural UNMET gala ....

United States , Brett Beber , Lina Policaro , Toni Zhong , Michael Cooper , Emmanuelle Gattuso , Teresa Vasilopoulos , Vonna Bitove , Vanessa Mulroney , Patrick Dovigi , Claire Macnamara , Duncan Jackman , Krystal Koo Cooper , Suzanne Boyd , Samuel Hall Curley , Ahmed Hussen , Jenna Bitove Naumovich , Charlotte Positano Girouard , Fernanda Dovigi , Roly Browning Watt , Galen Weston Jr , Edward Rogers , Beth Wilson , Anne Babcock , Needs Fundraising Campaign , Loblaw Companies Ltd ,

Govorestat (AT-007) Receives Orphan Medicinal Product Designation from the EMA for Treatment of SORD Deficiency

EMA Orphan Designation reflects high unmet need in SORD Deficiency and benefit of govorestat treatment in reducing toxic sorbitol levelsNew data published in Journal of Clinical Investigation further. | May 25, 2023 ....

Shoshana Shendelman , Sheyum Syed , Christopher Yanick , Mario Saporta , Natalie Ortiz Vega , Xianzun Tao , Amandag Lobato , Maeve Conneighton , Yi Zhu , Riccardo Perfetti , Adrianap Rebelo , Therapeutics Inc , European Medicines Agency , Exchange Commission , Clinical Investigation , Sorbitol Dehydrogenase , Medicinal Product Designation , Tijana Canic , Michael Shy , Dehydrogenase Deficiency , Aldose Reductase , About Applied , Aldose Reductase Inhibitor , Diabetic Cardiomyopathy , Private Securities Litigation Reform Act , Applied Therapeutics ,

AN2 Therapeutics to Present at Jefferies Healthcare Conference

AN2 Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today announced that. | May 25, 2023 ....

New York , United States , Eric Easom , Therapeutics Inc , Jefferies Healthcare , Healthcare Conference , An2 Therapeutics , Nc Stock Exchange , Press Release , Nnounced Antx Us0373261058 ,

REGENXBIO Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RGX-121 Gene Therapy for Hunter Syndrome

RMAT recognizes that the preliminary clinical evidence from RGX-121, a potential one-time AAV Therapeutic, indicates the potential to address unmet medical needs for MPS II RMAT designation is for. | May 23, 2023 ....

Dana Cormack , Joseph Muenzer , Terri Klein , Steve Pakola , Chris Brinzey , Technology Platform Licensees , Treatment Center , University Of North Carolina At Chapel Hill , Technology Platform , Corporate Communications , Manufacturing Innovation Center , Drug Administration , Innovation Center , Biologics License Application , Regenerative Medicine Advanced Therapy , Mucopolysaccharidosis Type , Chief Medical Officer , Century Cures Act , Bryson Distinguished Professor , Pediatrics Genetics , North Carolina , Chief Executive Officer , Heparin Sulfate , Orphan Drug Product , Rare Pediatric Disease , Fast Track ,